JP2002335964A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002335964A5 JP2002335964A5 JP2001131638A JP2001131638A JP2002335964A5 JP 2002335964 A5 JP2002335964 A5 JP 2002335964A5 JP 2001131638 A JP2001131638 A JP 2001131638A JP 2001131638 A JP2001131638 A JP 2001131638A JP 2002335964 A5 JP2002335964 A5 JP 2002335964A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- partial peptide
- amide
- ester
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 description 13
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 150000001408 amides Chemical class 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001131638A JP2002335964A (ja) | 2000-04-27 | 2001-04-27 | 新規タンパク質およびその用途 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-127547 | 2000-04-27 | ||
| JP2000127547 | 2000-04-27 | ||
| JP2001-64862 | 2001-03-08 | ||
| JP2001064862 | 2001-03-08 | ||
| JP2001131638A JP2002335964A (ja) | 2000-04-27 | 2001-04-27 | 新規タンパク質およびその用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002335964A JP2002335964A (ja) | 2002-11-26 |
| JP2002335964A5 true JP2002335964A5 (enExample) | 2008-06-05 |
Family
ID=27343222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001131638A Pending JP2002335964A (ja) | 2000-04-27 | 2001-04-27 | 新規タンパク質およびその用途 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2002335964A (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8555798A (en) * | 1997-08-01 | 1999-02-22 | Genset | 5' ests for secreted proteins expressed in muscle and other mesodermal tissues |
| DE69841110D1 (de) * | 1997-12-17 | 2009-10-08 | Serono Genetics Inst Sa | Verlängerte cdns, die für sekretierte proteine kodieren |
| CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| EP1686134A3 (en) * | 1999-12-01 | 2006-08-09 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
-
2001
- 2001-04-27 JP JP2001131638A patent/JP2002335964A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL210455A (en) | A polypeptide for reducing mammalian signaling 13il, and using a polypeptide to produce a drug for up-regulating gene expression 2ra13-il in mammals | |
| JP2006506942A5 (enExample) | ||
| CY1109631T1 (el) | Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ | |
| MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
| NO20025064L (no) | RGO koblet til peptider | |
| JP2001103993A (ja) | 環状ペプチド及びセリンプロテアーゼ阻害剤 | |
| EP1501936A4 (en) | PROTEIN FAMILY OF CYTOKINE | |
| CA2413195A1 (en) | Ligand to gpr8 and dna thereof | |
| JP2006507229A5 (enExample) | ||
| DE69925116D1 (de) | Neue, physiologisch aktive peptide und ihre verwendung. | |
| JP2002335964A5 (enExample) | ||
| WO2001064876A3 (en) | Human schizophrenia gene | |
| WO2003076658A3 (en) | A susceptibility gene for late-onset idiopathic parkinson's disease | |
| JP2002335976A5 (enExample) | ||
| JP2001069994A5 (enExample) | ||
| TW200517125A (en) | Pharmaceutical composition for treatment of solid cancers | |
| JP2002355060A5 (enExample) | ||
| JP2001269184A5 (enExample) | ||
| JP2004081196A5 (enExample) | ||
| JP2004513631A5 (enExample) | ||
| JP2007517775A5 (enExample) | ||
| JPH1143499A5 (enExample) | ||
| WO2003022300A1 (en) | Preventives/remedies for bone/joint diseases | |
| JP2002348254A5 (enExample) | ||
| JP2003144177A5 (enExample) |